Market Tracker

10/31 10:00pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

4.83
Data as of Oct 31
 -0.03 / -0.62%
Today’s Change
3.10
Today|||52-Week Range
7.45
-9.38%
Year-to-Date

Today’s Trading

Previous close4.86
Today’s open5.00
Day’s range4.78 - 5.00
Volume478,672
Average volume (3 months)879,752
Market cap$336.0M
Dividend yield--
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)+25.49%
Earnings growth (this year)+97.37%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-44.03%
P/E ratioNM
Price/Sales37.83
Price/Book3.72

Competitors

 Today’s
change
Today’s
% change
XNCRXencor Inc+0.29+2.76%
ZIOPZIOPHARM Oncology In...+0.26+8.50%
AGTCApplied Genetic Tech...+0.01+0.05%
CORTCorcept Therapeutics...-0.21-6.07%
Data as of 3:59pm ET, 10/31/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$7.9M
Annual profit (last year)-$42.6M
Net profit margin-541.49%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Treasurer, CAO &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts